Citation Formats
In Reply: Pharmacological Venous Thromboembolism Prophylaxis in Meningioma Patients: Should it be Earlier than in Clinical Practice?
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. Celtikci, "In Reply: Pharmacological Venous Thromboembolism Prophylaxis in Meningioma Patients: Should it be Earlier than in Clinical Practice?," TURKISH NEUROSURGERY , vol.28, no.1, pp.166, 2018

Celtikci, E. 2018. In Reply: Pharmacological Venous Thromboembolism Prophylaxis in Meningioma Patients: Should it be Earlier than in Clinical Practice?. TURKISH NEUROSURGERY , vol.28, no.1 , 166.

Celtikci, E., (2018). In Reply: Pharmacological Venous Thromboembolism Prophylaxis in Meningioma Patients: Should it be Earlier than in Clinical Practice?. TURKISH NEUROSURGERY , vol.28, no.1, 166.

Celtikci, Emrah. "In Reply: Pharmacological Venous Thromboembolism Prophylaxis in Meningioma Patients: Should it be Earlier than in Clinical Practice?," TURKISH NEUROSURGERY , vol.28, no.1, 166, 2018

Celtikci, Emrah. "In Reply: Pharmacological Venous Thromboembolism Prophylaxis in Meningioma Patients: Should it be Earlier than in Clinical Practice?." TURKISH NEUROSURGERY , vol.28, no.1, pp.166, 2018

Celtikci, E. (2018) . "In Reply: Pharmacological Venous Thromboembolism Prophylaxis in Meningioma Patients: Should it be Earlier than in Clinical Practice?." TURKISH NEUROSURGERY , vol.28, no.1, p.166.

@article{article, author={Emrah Celtikci}, title={In Reply: Pharmacological Venous Thromboembolism Prophylaxis in Meningioma Patients: Should it be Earlier than in Clinical Practice?}, journal={TURKISH NEUROSURGERY}, year=2018, pages={166} }